Expression of fibronectin splice variants in the postischemic rat kidney. Am J Physiol Renal Physiol 280: F1037-F1053, 2001.-Using an in vivo rat model of unilateral renal ischemia, we previously showed that the expression and distribution of fibronectin (FN), a major glycoprotein of plasma and the extracellular matrix, dramatically changes in response to ischemia-reperfusion. In the distal nephron in particular, FN accumulates in tubular lumens, where it may contribute to obstruction. In the present study, we examine whether the tubular FN is the plasma or cellular form, each of which is produced by alternative splicing of a single gene transcript. We demonstrate that FN in tubular lumens does not contain the extra type III A (EIIIA) and/or the extra type III B (EIIIB) region, both of which are unique to cellular FN. It does, however, contain the V95 region, which in the rat is a component of FNs in both plasma and the extracellular matrix. Expression of FN containing EIIIA increases dramatically in the renal interstitium after ischemic injury and continues to be produced at high levels 6 wk later. V95-containing FN also increases in the interstitial space, albeit more slowly and at lower levels than FN containing EIIIA; it also persists 6 wk later. FN containing the EIIIB region is not expressed in the injured kidney. The presence of V95 but not the EIIIA or EIIIB regions of FN in tubular lumens identifies the origin of FN in this location as the plasma; tubular FN is ultimately voided in the urine. The data indicate that both plasma and cellular FNs containing the V95 and/or EIIIA regions may contribute to the pathogenesis of acute renal failure and to the repair of the injured kidney. alternative splicing; extracellular matrix; renal injury; regeneration; acute renal failure FIBRONECTINS (FNs) ARE A FAMILY of large (ϳ440 kDa) dimeric glycoproteins implicated in a variety of biological processes, including tissue remodeling during wound healing and embryonic development (for review, see Refs. 29, 40) . FNs influence these processes by affecting cell adhesion and extracellular matrix assembly. They exist in two forms, plasma and cellular. Plasma FN is made by hepatocytes and circulates in the blood; cellular FN is produced by epithelial and connective tissue cells and is deposited into the extracellular matrix. Both forms of FN are encoded by a single gene, whose transcript can be alternatively spliced at three intron-exon boundaries, yielding FN protein subunits containing, in the rat, the extra type III A (EIIIA) repeat, the extra type III B (EIIIB) repeat, and/or the variable (V) region ( Fig. 1 ; for review, see 19, 51-52). Equivalent regions in humans are designated EDA, EDB, and IIICS. During splicing of FN mRNA, these exons are either included or excluded depending on the tissue and cell type. In plasma FN mRNA, exons encoding the EIIIA and EIIIB segments are excluded, whereas the exon encoding the V region is either partially or completely included depending on the species. In cellular FN mRNA, EIIIA and/or EIIIB exons are wholly retained and the V region appears to be at least partially included (43, 45, 56) . Up to 12 different combinations of the three alternatively spliced segments are possible, resulting in a heterogeneous mixture of FN isoforms (32, 53) .
alternative splicing; extracellular matrix; renal injury; regeneration; acute renal failure FIBRONECTINS (FNs) ARE A FAMILY of large (ϳ440 kDa) dimeric glycoproteins implicated in a variety of biological processes, including tissue remodeling during wound healing and embryonic development (for review, see Refs. 29, 40) . FNs influence these processes by affecting cell adhesion and extracellular matrix assembly. They exist in two forms, plasma and cellular. Plasma FN is made by hepatocytes and circulates in the blood; cellular FN is produced by epithelial and connective tissue cells and is deposited into the extracellular matrix. Both forms of FN are encoded by a single gene, whose transcript can be alternatively spliced at three intron-exon boundaries, yielding FN protein subunits containing, in the rat, the extra type III A (EIIIA) repeat, the extra type III B (EIIIB) repeat, and/or the variable (V) region ( Fig. 1 ; for review, see 19, [51] [52] . Equivalent regions in humans are designated EDA, EDB, and IIICS. During splicing of FN mRNA, these exons are either included or excluded depending on the tissue and cell type. In plasma FN mRNA, exons encoding the EIIIA and EIIIB segments are excluded, whereas the exon encoding the V region is either partially or completely included depending on the species. In cellular FN mRNA, EIIIA and/or EIIIB exons are wholly retained and the V region appears to be at least partially included (43, 45, 56) . Up to 12 different combinations of the three alternatively spliced segments are possible, resulting in a heterogeneous mixture of FN isoforms (32, 53) .
The function of the various isoforms is incompletely understood. FNs retaining the EIIIA and/or EIIIB regions are widely expressed in embryonic tissues and cultured cell lines compared with normal adult tissues (12, 20-21, 43-44, 46-47, 53, 64) . Upregulation of EIIIA-and/or EIIIB-containing FN has also been noted in the adult at sites of tissue injury, such as in the skin (14, 22) , eye (41, 67) , and vasculature (17, 25, 28, 60) . Isoforms containing a subsegment of the V region known as V25 are also preferentially expressed in embryos and injured peripheral nerves (37, 68) .
In the kidney, FN isoforms are differentially expressed during development. In human fetal kidney, FN containing the EDA segment is widely found in tubular and glomerular basement membranes, the interstitium, and glomerular mesangium (34) . The isoform containing the EDB region follows a similar but more restricted distribution, localizing to the mesangium, the interstitium, and basement membranes of medullary tubules and collecting ducts, albeit at lower levels (34) . In the adult human nephron, FN containing EDA is found only in the mesangium; neither EDA-nor EDB-containing FNs are detected in tubular basement membranes or the interstitial compartment (34) .
We previously demonstrated in an in vivo model of unilateral renal ischemia that FN strongly increases in expression and changes its distribution in response to injury (76) . In particular, high concentrations of FN were observed in tubular lumens, suggesting a possible role in tubular obstruction. This study was initiated to understand whether tubular FN originated from plasma or from epithelial and/or connective tissue cells after ischemic injury. We demonstrate that luminal FN originates from plasma and is voided in the urine. We also observe that in response to ischemiareperfusion, FN containing the EIIIA and/or V segments dramatically increases and V-FN, in particular, changes its distribution. These observations have important implications for understanding the mechanism(s) involved in the pathophysiology of acute renal failure (26, 62) .
MATERIALS AND METHODS
Surgical procedure. A unilateral rat model of renal ischemia in which the renal artery and vein are clamped for 40 min whereas the contralateral kidney is left intact was used in this study.
Male Sprague-Dawley rats (190-275; Charles River Breeding Laboratories, Wilmington, MA) were housed for 6 days before surgery in the animal facility under alternating cycles of 12 h light, 12 h dark. Water and rat chow were administered ad libitum. In preparation for surgery involving unilateral renal ischemia without removal of the contralateral kidney, animals were weighed and 5-10 ml of sterile saline at 37°C were injected intraperitoneally. Animals were then anesthesized with pentobarbital sodium (6.5 mg/100 g; Abbott Laboratories, North Chicago, IL), and shaved over the left flank. Each was positioned on a warm operating platform (Homeothermic Control Unit; Harvard Apparatus, Holliston, MA) maintained at 37°C, and an incision was made over the left flank region. The renal artery, vein, and ureter were dissected free of surrounding tissue; only the renal artery and vein were clamped with a microaneurysm clamp (Roboz Surgical Instruments, Washington, DC). The incision was temporarily closed, and the animal was placed in an enclosed chamber at 37°C (Small Animal Intensive Care Unit, Harvard Apparatus). After 40 min, the clamp was removed, allowing the kidney to be reperfused with blood. The incision was then permanently sutured, and, after recovery, animals were placed in metabolic cages (Nalgene Labware, Rochester, NY). At the stated times after reperfusion, both kidneys (left postischemic and right contralateral) were either fixed in situ for immunocytochemistry or excised and frozen in liquid nitrogen for biochemistry (see Tissue harvesting). Some animals underwent sham surgery without ischemia. For sham surgery, in lieu of clamping the renal artery and vein, the left kidney was surgically exposed and gently manipulated.
In the unilateral model of renal ischemia, there are only mild systemic changes in blood urea nitrogen and creatinine because of the presence of the intact contralateral kidney (36, 72) .
Urine collection. Urine was collected at 24-h intervals in the presence of Complete protease inhibitors (BoehringerMannheim, Indianapolis, IN) from animals housed in metabolic cages (100 l of 50ϫ protease inhibitor/collection tube). The volume collected was measured, and the urine was filtered through two layers of cheesecloth before being centrifuged at 2,000 rpm at 0°C for 30 min. Urine was then filtered through a 0.45-m Millex-HA filter (Millipore, Bedford, MA), aliquoted, and frozen in liquid nitrogen. Samples were stored at Ϫ80°C.
Tissue harvesting. Animals were anesthetized before tissue harvesting. For immunocytochemistry, rats were perfused through the left ventricle with warm Hanks' balanced salt solution and then with 2% paraformaldehyde-75 mM L-lysine-10 mM sodium periodate (PLP; 38). Kidneys were removed and stored intact in fixative overnight at 4°C. They were then rinsed in PBS and stored in PBS containing 0.02% sodium azide at 4°C.
For biochemical analysis, rats were perfused through the left ventricle with sterile PBS (Dulbecco's formulation) at 0°C containing 0.16ϫ complete protease inhibitors (BoehringerMannheim). Kidneys were removed, placed on ice, and dissected free of adherent connective tissue. Slices were cut, extending from the cortex to the hilus, frozen in liquid nitrogen, and stored at Ϫ80°C.
Antibodies. A variety of monoclonal and polyclonal antibodies against FN were used in this study. Rabbit anti-rat FN polyclonal antibody (GIBCO-BRL, Grand Island, NY) was generated against rat plasma FN. This antibody recognizes regions of the FN molecule that are common to both the plasma and cellular forms. It was used to detect all forms of FN in tissue sections (1:750) and immunoblots (1:7,500). It is therefore referred to as anti-total FN antibody. Specificity of the anti-total FN antibody was determined by competition experiments between the antibody and purified antigen (76) . Briefly, the anti-total FN antibody was incubated with purified rat plasma fibronectin, and the mixture then applied to tissue sections. After rinsing, sections were processed as described below for immunocytochemistry. Under these conditions, immunostaining was obliterated (76) .
Culture supernatant containing mouse monoclonal antibody against the EDA region of human cellular FN was obtained from I. Virtanen (Univ. of Helsinki, Helsinki, Finland; 64). Alternatively, the same purified antibody was purchased from Chemicon International (Temecula, CA). This antibody specifically recognizes the extra domain of Fig. 1 . Schematic illustration of 1 subunit of a fibronectin (FN) dimer in the rat. FN consists of a series of type I, II, and III repeats, each of which is specialized into binding domains with affinities for fibrin, collagen, cells, and heparin. The role of the first seven type III repeats (III, 1-7) is incompletely understood. The EIIIB and EIIIA (extra type III, A and B) repeats that are produced by alternative splicing of mRNA are darkened. The V120 region that is also alternatively spliced is illustrated by a rectangle with shaded (V25) and hatched (V95) areas. An arginine-glycine-aspartic acid (RGD) sequence present in the cell binding domain and a PEILDV sequence in V25 interact with the ␣5␤1 and ␣4␤1 integrins, respectively. Arginine-arginine (RR) in the heparin domain mediates binding to heparin. The synergistic site (brackets) in cooperation with RGD promotes full cell spreading [redrawn from Schwarzbauer (51) ].
human cellular FN (EDA sequence) but also cross-reacts with the rat EIIIA region (Chemicon International; see also Figs. 5-7). Culture supernatant was used undiluted for immunofluorescence whereas purified antibody was used at a 1:1,000 dilution to immunoblot kidney tissue extracts and urine. Rabbit polyclonal antibody R2640 to the rat EIIIB segment was obtained from R. O. Hynes (46, 47) and used at a 1:100 dilution. This antibody recognizes the EIIIB segment in the context of a bacterial fusion protein because the immunogen was an EIIIB-glutathione S-transferase fusion protein. In order for this antibody to recognize EIIIB in mammalian cells, N-linked carbohydrate was removed from target FN by pretreating tissue sections overnight with N-glycanase (46, 47; see cryosectioning and immunofluorescence). Rabbit polyclonal antibody 73N recognizing the V95 region of FN was also obtained from R. O. Hynes (46, 47) and was used at a dilution of 1:100 for immunocytochemistry. This region is one of three variants of the V segment found in rat (V120, V95, and V0). Both the rabbit polyclonal antibody R2640 to the rat EIIIB segment and rabbit polyclonal antibody 73N to the V95 region of FN are suitable for immunocytochemistry (7, 42, 46, 47) and not biochemistry. These antibodies have been used for studies in the kidney (7, 42, 46) .
Cryosectioning and immunofluorescence. For frozen sections, fixed intact kidneys were sliced and equilibrated overnight at 4°C in 0.6 M sucrose/PBS. Kidney slices were then embedded in OCT (optimal cutting temperature) compound (Miles Laboratories, Naperville IL) and frozen in liquid nitrogen. Sections (5 m) were cut on either a Reichert Frigocut cryostat (Leica, Deerfield, IL) or a Leica CM1850 cryostat. Sections were placed on SuperFrost Plus glass slides (Fisher Scientific, Boston, MA) and stored at Ϫ20°C until use.
For immunostaining, the procedure of Zuk et al. (76) was used. Briefly, sections were fixed to the slides by incubating in PLP followed by washing in PBS. Autofluorescence was then quenched with sodium borohydride/PBS (1 mg/ml). After washing, sections were permeabilized with 0.1% Triton X-100/PBS and washed again. To immunostain the rat EIIIB segment, tissue sections were enzymatically digested with N-glycanase (50,000 units/ml; New England Biolabs, Beverly, MA) at 37°C overnight (46, 47) . Nonspecific binding sites were then blocked with 10% normal goat serum. Sections were incubated in primary antibody overnight at 4°C followed by washing and incubation in secondary antibody. These antibodies were either goat anti-rabbit FITC adsorbed against mouse and human Ig (1:200; BioSource International, Camarillo, CA) or goat anti-mouse indocarbocyanine (CY3) adsorbed against rat, human, bovine, and horse serum proteins (1:800; Jackson ImmunoResearch Laboratories). Sections were washed, mounted in VectaShield (Vector Laboratories, Burlingame, CA) and viewed on a Zeiss Axoplan, Axiophot, or Axiovert microscope (Carl Zeiss, Thornwood, NY). Images were recorded on TMAX 400 film (Eastman Kodak, Rochester, NY) at ASA 800.
Controls for immunostaining included omitting the primary and/or secondary antibody and immunostaining tissue sections known to contain the antigen of interest. In all cases, kidney sections serving as control were from the same animal and time point (ischemic, contralateral or sham-operated kidney). Immunostaining was repeated at least three times on sections from at least two animals for each time point and condition.
Fluorescence staining intensity was subjectively graded as follows: (-), absent; (ϩ), faint; (ϩϩ), moderate; and (ϩϩϩ), strong. These grades pertain to the overall intensity of staining within the tissue, rather than to a particular structure within it. Tissue staining patterns produced by the anti-total and anti-segment-specific antibodies include: B, basement membrane zone; I, renal interstitium; L, tubular lumen of the distal nephron; and C, renal corpuscle.
Western Blotting
Immunoblotting was repeated at least three times with samples from a minimum of two animals for each time point and condition.
Tissue samples. Frozen kidney tissue was quickly weighed and transferred to a Dounce homogenizer on ice. Nine parts 2ϫ sample buffer (400 mM Tris, pH 8.8, 10 mM EDTA, 2% SDS) at 4°C containing protease inhibitors (10 g/ml aprotinin, 1 g/ml antipain, 1 g/ml pepstatin, 17.5 g/ml benzamidine) but lacking sucrose, bromophenol blue and dithiothreitol (DTT) were then added. Tissue was extensively homogenized and boiled for a total of 8 min at 95°C to completely solubilize cell proteins. Samples were then cooled to room temperature, DTT was added to 40 mM, and samples were further homogenized and boiled (4 min). After cooling to room temperature, samples were sheared in succession with 22-, 23-, and 26-gauge needles, transferred to microfuge tubes, and spun twice at 16,000 g for 5 min at room temperature. Any remaining pellet was reextracted (2ϫ sample buffer containing DTT, SDS, and protease inhibitors), sheared, and centrifuged as before. Supernatants were pooled, and protein concentration was then measured using the Standard Bio-Rad Protein Assay (Bio-Rad, Hercules, CA) with BSA as standard.
Urine samples. Urine samples were thawed on ice for 15-20 min and centrifuged for 5 min at 4°C. Typically, no pellet was visible. Volumes of urine containing equivalent amounts of protein were mixed with an equal volume of 2ϫ sample buffer containing 24% sucrose, 0.2% bromophenol blue, 40 mM DTT and protease inhibitors. Samples were boiled at 95°C for 4 min and quickly cooled on ice.
Tissue and urine samples were further diluted with 1ϫ sample buffer (200 mM Tris, pH 8.8, 5 mM EDTA, 12% sucrose, 0.1% bromophenol blue, 20 mM DTT, 2% SDS) without protease inhibitors to yield aliquots of protein suitable for gel loading. They were then boiled again, cooled, alkylated with 0.5 M iodoacetamide in the dark at 37°C for 20 min, and either frozen in liquid nitrogen and stored at Ϫ80°C or used immediately.
Samples were resolved by 6% SDS-PAGE (33) . For immunoblotting, gels were equilibrated in transfer buffer (20% methanol, 48 mM Tris, 0.038% SDS, 39 mM glycine) for 20 min, and proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Immobilin-P, Millipore) at 90 mA for 72 min. To confirm equal transfer of proteins, membranes were stained with Coomassie blue and then destained. Membranes were washed with 10 mM Tris, pH 7.5, 100 mM NaCl, and 0.1% Tween 20, blocked in 5% nonfat dry milk in wash buffer, and incubated in primary antibody overnight at 4°C with rotation. Membranes were washed extensively, reacted with secondary antibody conjugated to horseradish peroxidase (HRP; donkey anti-rabbit HRP or donkey anti-mouse HRP; Jackson ImmunoResearch Laboratories, Westgrove, PA) for 1 h at room temperature, and washed again. HRP was reacted with either 0.05% diaminobenzidine (Sigma, St. Louis, MO) or Renaissance chemiluminescence reagents (NEN Life Science Products, Boston, MA). For the latter, membranes were exposed to either X-OMAT Blue (Eastman Kodak) or Reflection (DuPont-NEN) autoradiography films. Films were developed with a Kodak X-OMAT processor.
RESULTS
We and others have previously demonstrated in in vivo rat models of renal ischemia that cell extracellular matrix interactions dynamically change in response to injury (70, 76) . In particular, we demonstrated that FN, a major glycoprotein of the plasma and renal interstitium, significantly altered its distribution and expression. Most surprisingly, it was intensely immunostained in tubular lumens. In this location, FN might contribute to tubular obstruction, a major outcome of renal artery occlusion and reperfusion. Because our earlier work did not distinguish among the various forms of FN, we were unable to determine whether lumenal FN originated from leakage of plasma proteins or from the synthesis and deposition of the cellular form by tubular epithelial or connective tissue cells. Resolution of this issue is important for our understanding of how FN is involved in the pathogenesis of ischemic renal injury. To investigate the source of luminal FN, polyclonal and monoclonal antibodies against specific regions of this molecule that are found in either plasma and/or cellular FNs (EIIIA, EIIIB, and V95) were used to determine the distribution of plasma and cellular FNs in response to ischemia reperfusion.
Distribution and Expression of FN in the Outer and Inner Stripes
Total FN. Using a polyclonal antibody that recognizes both plasma and cellular FNs, referred to as anti-total FN antibody, FN was immunolocalized in kidney sections of rats killed at various times after reperfusion after a 40-min unilateral clamp of the renal artery and vein. In kidneys made ischemic but not reperfused (0 h postischemia, Fig. 2 , A and B), anti-total FN antibody outlines tubules in the outer stripe ( Fig. 2A ) and inner stripe (Fig. 2B) ; it also stains the interstitial space (Figs. 2, A and B). One to three hours after reperfusion, localization is maintained (outer stripe, Fig. 2C ; inner stripe, Fig. 2D ). However, anti total-FN antibody also stains the luminal space of some tubules of the thick ascending limb in the inner stripe (asterisks, Fig. 2D ).
At 24 -48 h after reperfusion, total FN immunostaining increases, strongly outlining the perimeter of tubules in both the outer and inner stripes and localizing in a fibrillar pattern to the interstitial compartment. In the outer stripe (Fig. 2E ), where injury is most evident (16, 24, 50) , diffuse total FN staining is observed in the lumens of S3 proximal tubules (asterisks, Fig. 2E ). Staining of total FN within tubular spaces of other nephron segments coursing through this region is absent at this time (76) . Most interestingly, in the inner stripe of the outer medulla, strong FN immunoreactivity is detected in the lumen of many tubules of the thick ascending limb (asterisks, Fig. 2F ; 76) .
By 120 h after reperfusion, total FN is absent from tubular lumens of proximal S3 (Fig. 2G ) and distal nephron segments (Fig. 2H) . However, it continues to be strongly expressed in a fibrillar pattern in an expanded interstitium in the outer (Fig. 2G) and inner ( Fig. 2H ) stripes.
In normal (76) , contralateral, and mock-operated (mock) kidneys at all time points, anti-total FN antibody outlines tubules in the outer and inner stripe; it also stains the interstitial space (for contralateral outer and inner stripes at 24 h, see Fig. 3 , A and B, respectively; for mock outer and inner stripes at 24 h, see Fig. 3 , E and F, respectively; for contralateral outer and inner stripes at 120 h, see Fig. 3 , C and D, respectively; for mock outer and inner stripes at 120 h, see Immunoblotting of kidney extracts confirms the increase in total FN in response to ischemic reperfusion injury ( The accumulation of FN identified with the anti-total FN antibody in tubular lumens and interstitial compartments raised the question of which form, plasma and/or cellular, localized to these regions. Immunolocalization of the EIIIA segment unique to cellular FN was first examined using a monoclonal antibody generated against the human EDA site that cross-reacts with rat EIIIA.
EIIIA-FN. At 0 h postischemia, FN containing the EIIIA segment is not detected in the outer ( . Production of EIIIA-FN significantly increases 1-3 h after reperfusion, associating primarily with basement membranes of S3 proximal tubules in the outer stripe ( Fig. 5C ) and thick limbs of the inner stripe (Fig. 5D) . Interstitial localization in the inner stripe is also strong. FN containing the EIIIA segment is not detected in tubular lumens of the inner stripe (Fig. 5D) , in contrast to the observation with anti-total FN antibody (Fig. 2D) .
At 24 and 48 h after ischemia-reperfusion injury, a further increase in immunostaining for EIIIA-FN in the outer and inner stripes is observed. FN containing EIIIA associates with both the interstitial matrix and renal basement membrane (outer stripe, Fig. 5E and inner stripe, Fig. 5F ). In the outer stripe especially (Fig. 5 E) , the interstitial space appears enlarged. EIIIA-FN is absent from tubular lumens in the outer (Fig. 5E ) and inner stripes (Fig. 5F ), in contrast to the presence of total FN in this location at this time (see Fig. 2 , E and F for outer and inner stripes, respectively). At 120 h after reperfusion, strong reactivity for FN containing EIIIA persists in an expanded interstitial matrix (outer stripe, Fig. 5G and inner stripe, Fig. 5H ), consistent with previous observations (9) . Again, none is found in the luminal space (outer stripe, Fig. 5G and inner stripe, Fig. 5H ).
In contralateral kidneys at 0 h, EIIIA-FN is rarely detected in the outer medulla (data not shown), similar to that observed in the postischemic kidney at this time point (see Fig. 5, A and B) . However, at 1-3 h, FN containing EIIIA begins to be associated with the renal interstitium and basement membrane of tubules in the outer (Fig. 6A) and inner ( , total FN continues to localize to these regions; however, in the outer stripe (C), it also highlights broken basement membrane (arrow). In the inner stripe (D), it is detected in a few tubular lumens (asterisks). At 24 h postischemia (E-F), interstitial staining for total FN increases. The frequency of tubular FN is also greater within lumens of the outer (E) and inner (F) stripes (asterisks). By 120 h postischemia (G-H), luminal FN is not detected in the outer (G) or inner (H) stripes; however, interstitial FN staining remains strong. The faint apical staining in G is nonspecific. Bar ϭ 40 m.
points (for 24 and 120 h, see Fig. 6 , E and G, respectively; data not shown for 0 and 3 h); infrequently, some faint immunostaining is seen in the inner stripe (for 24 and 120 h, see arrows Fig. 6 , F and H, respectively; data not shown for 0 and 3 h).
To confirm biochemically our immunocytochemical observations, tissue extracts were prepared for immunoblotting from normal, 0-, 1-, 3-, 24-, 48-, and 120-h postischemic as well as contralateral control or mock-operated kidneys. Western blots showed that FN containing the EIIIA segment increases in response to ischemic injury. Levels of EIIIA-FN significantly rise at 24 h in ischemic kidneys (Fig. 7A) and remain elevated at 48 and 120 h (Fig. 7A ) compared with contralateral ( Fig. 7B) and mock (Fig. 7C) kidneys at corresponding time points. In contrast to the immunostaining data, however, significant levels of EIIIA-FN at 3 h postischemia (Fig. 7A ) or in contralateral kidneys (Fig. 7B) are not always detected. This may be due to low levels of expression localized to only a limited region of the kidney that is below the limit of detectability when the entire kidney is taken for Western blot analysis. The appearance of EIIIA-FN at low levels in mock kidneys at each time point may represent normal expression in the papillary region detected by immunostaining (data not shown). Such immunostaining is also present in contralateral kidneys (data not shown).
EIIIB-FN. FN containing the EIIIB region was examined next. EIIIB, like EIIIA, is unique to cellular FN. EIIIB-FN was not detected in kidney sections at any of the time points examined after ischemic injury. It is also not detected in normal adult rat (42, 44) , mouse (46) , or human (34) kidneys. As a positive control for immunostaining, EIIIB-FN was detected in Descemet's membrane of the adult rat cornea (data not shown; 46).
V95-FN.
Localization of the V95 region of FN, which in the rat is found in a fraction of both plasma and cellular FNs (54, 55) , was also examined. At 0 h postischemia, little if any FN containing the V95 region is detected in the outer (arrows, Fig. 8A ) and inner stripes (Fig. 8B ). One to three hours later, localization in the outer stripe (Fig. 8C) does not change; however, in the inner stripe (Fig. 8D) , FN containing V95 begins to localize to some lumenal compartments (asterisks, Fig. 8D) .
At 24-48 h after reperfusion, the interstitial matrix between renal tubules of the outer stripe (Fig. 8E) is strongly highlighted whereas, in the inner stripe (Fig.  8F) , delicate staining predominates in the interstitial space. V95-FN is also detected more frequently at high levels in luminal compartments (asterisks, Fig. 8F ). At 120 h postischemia, immunostaining becomes intense in an expanded interstitium in both the outer (Fig. 8G ) and inner (Fig. 8H ) stripes but is no longer detected in tubular lumens (inner stripe, Fig. 8H ).
In contralateral and mock kidneys at 0 and 1-3 h, localization of V95-FN is comparable to that observed in corresponding postischemic animals (see Fig. 8,  A-D) ; i.e., little if any is detected in the outer medulla (data not shown). Contrary to the postischemic animal at 3 h, however, FN containing V95 is not found in the luminal space (data not shown). At 24, 48, and 120 h in contralateral kidneys, some interstitial staining of V95 FN begins to be observed; however, immunostaining is not extensive because the interstitium is not enlarged (data not shown) as in ischemic animals at these times. In addition, V95-FN is not detected in the luminal space (data not shown). Mock animals at 24, 48, and 120 h show infrequent, faint staining of the interstitium (data not shown), similar to that observed at 0 and 1-3 h postischemia (see Fig. 8, A-D) ; luminal staining, however, is not observed at any time point (data not shown).
Thus in response to ischemia-reperfusion, FN containing the EIIIA but not the EIIIB region increases dramatically in the outer and inner stripes of the injured kidney and continues to be produced at high levels 120 h later. FN containing V95 also increases, albeit more slowly and at lower levels than EIIIA; it also persists at 120 h. Both EIIIA and V95-FNs localize to the interstitium and surround tubular basement membranes. V95-, but not EIIIA-or EIIIB-containing FN, is found in tubular lumens of the distal nephron as early as 3 h after reperfusion in the injured kidney, disappearing by 120 h postischemia. 
Distribution and Expression of FN Isoforms in the Cortex
FN isoforms were also immunolocalized in the cortex after ischemic injury to determine whether either expression or distribution in this region was affected, as in the outer and inner stripes. We also examined whether the immunostaining pattern provided evidence of glomerular damage, which could explain the source of luminal FN in both this and our previous study (76) . Glomerular injury would disrupt the glomerular filtration barrier, allowing access of plasma proteins (greater than 70 kDa) such as FN into Bowman's space.
Total FN. At 0 (Fig. 9A), 1, 3 (Fig. 9B) , 24, 48 ( Fig.  9C) , and 120 h (Fig. 9D) Figs. 9, A-D) ; however, from 3 to 48 h after reperfusion, it is more frequently detected in tubular lumens of the distal nephron adjacent to glomeruli (double asterisk, Figs. 9, B and C, respectively). The latter observation of FN in tubular lumens of nephron segments distal to glomeruli is consistent with results from the outer (see Fig. 2E ) and inner stripes (see Fig. 2, D and F) .
At all time points after ischemic reperfusion injury (Figs. 9, A-D) , total FN outlines basement membranes of proximal and distal tubules in the cortex. Between 24 and 48 h after injury, it also strongly localizes to the renal interstitium (Fig. 9C) . At 120 h postischemia, as seen in the outer and inner stripes (see Figs. 2, G and  H, respectively) , immunostaining of an expanded interstitium remains intense and total FN is no longer detected in the lumenal space (Fig. 9D) .
Similar localization of total FN outlining glomeruli and proximal and distal tubules is observed in contralateral (see Fig. 10, A and B representing the 24 and 120 h time points, respectively; data not shown for 0 and 3 h) and mock kidneys (see Fig. 10 , E and F representing the 24 and 120 h time points, respectively; data not shown for 0 and 3 h). Contrary to the postischemic kidney (for 3 and 48 h, see Fig. 9 , B and C, respectively), however, lumenal staining is not present 
Interstitial staining does not increase at 24 h (C-D) nor is EIIIA-FN detected in tubular lumens (C-D). In sham-operated kidneys (E-H), FN containing EIIIA is absent in the outer stripe (E, G) and is barely detected in the inner stripe (arrows, F, H). Bar ϭ 28 m.
in the distal nephron adjacent to glomeruli at any time (for contralateral and mock representing the 24 h time point, see Fig. 10 , A and E, respectively). Interstitial staining also does not increase (for contralateral and mock representing the 24 and 120 h timepoint, see Fig.  10 , A-B and E-F, respectively), contrary to that observed in the postischemic kidney where the interstitium expands (compare to Fig. 2 , E-H for 24 and 120 h, respectively; Fig. 9D, 120 h) .
EIIIA-FN. Immunostaining of both glomeruli and the interstitium of the cortex was examined with antibody recognizing the EIIIA region of FN. In glomerular regions at 0 h postischemia, anti-EIIIA antibody faintly demarcates the connective tissue of the capillary tuft ( Fig. 11A; 34 ). This staining pattern does not change 1-3 h after reperfusion (data not shown). However, 24-48 h after injury (Fig. 11B) , components of the renal corpuscle, including Bowman's capsule, stain more intensely, persisting at 120 h postischemia (Fig.  11C) . FN containing EIIIA does not localize to Bowman's space at any time after reperfusion (asterisk, Figs. 11, A-C) and is absent from tubular lumens of the distal nephron.
FN containing the EIIIA region was also localized in the cortical interstitium. At 0 h postischemia (Fig.  11A) , EIIIA-FN does not associate with tubular basement membranes or the interstitial matrix, in agreement with the immunostaining data in the outer medulla at this time (see Figs. 5, A and B) . Interestingly, no increase at 3 h postischemia is observed (data not shown), in contrast to the rise of EIIIA-FN in the outer and inner stripes (see Fig. 5, C and D) . At 24-48 h after injury, distribution of EIIIA-FN in the cortical interstitium is unusual and does not recapitulate earlier FN. A, C , E, and G represent the outer stripe of the outer medulla whereas B, D, F, and H represent the inner stripe of the outer medulla. At 0 h reperfusion (A-B), FN containing the V95 region is not detected in the outer medullary region except for infrequent patchy distribution that faintly associates with renal tubules (arrow, A). It is rarely detected in the interstitium 3 h after reperfusion (arrow, C) when it begins to localize to the luminal space of some thick limbs in the inner stripe (asterisks, D). At 24 h after reperfusion (E-F), staining intensity for FN containing V95 increases in the interstitium around S3 proximal tubules (E); in the inner stripe a delicate fibrillar staining is seen between tubules (F). Localization of the V95 isoform to lumens of thick ascending limbs also increases at this time (asterisks, F). At 120 h after reperfusion (G-H), FN containing V95 continues to increase in the interstitial compartment of the outer medulla, associating with basement membranes of renal tubules; V95-FN is absent from the luminal space in the inner stripe. Bar ϭ 40 m.
patterns observed with this antibody. Indeed, a gradient of staining is frequently detected with greater intensity of localization in cortical areas near the outer medullary region (Fig. 11B) where injured S3 proximal tubules reside. Localization is confined to an expanded interstitium, including areas juxtaposed to basement membranes. The interstitial matrix in cortical areas distant from the outer medulla shows weaker localization (Fig. 11B) or does not stain at all (data not shown). At 120 h postischemia, immunostaining of an expanded interstitium remains intense (Fig. 11C) . A gradient of staining continues to be present to some extent, with greater intensity in regions adjacent to the outer medullary region, diminishing in regions distant from it.
In contralateral kidneys at all time points, FN containing EIIIA identifies the connective tissue elements of the glomerulus and does not appear to localize to the interstitium surrounding proximal and distal tubules (Fig. 10, C and D, representing the 24 and 120 h time points, respectively; data not shown for 0 and 1-3 h). Faint immunostaining of glomerular connective tissue is observed in mock kidneys at all time points (arrows, Fig. 10 , G and H, representing the 24 and 120 h time points, respectively; data not shown for 0 and 1-3 h). Again, none is detected in the interstitium.
EIIIB-FN. The FN isoform containing the EIIIB region was not detected in the cortex either before (42) or after ischemic injury (data not shown).
V95-FN. Distribution and expression of FN containing the V95 region was examined in the glomerular and interstitial regions of the cortex. In the glomerular region at 0 (Fig. 11D), 3 (data not shown), 48 (Fig. 11E) , and 120 h (Fig. 11F) postischemia, V95-FN weakly localizes to the connective tissue surrounding the capillary tuft and steadily increases in Bowman's capsule. FN containing V95 is absent from the urinary space at all times after reperfusion (asterisk, Fig. 11 , D-F) but is sometimes seen in the lumen of the distal nephron between 3 and 48 h after reperfusion (data not shown).
V95-FN also localizes to the cortical interstitium. From 0 (Fig. 11D ) to 3 h (data not shown) postischemia, immunostaining with the anti-V95-FN antibody is rarely detected, consistent with our observation in the outer and inner stripes at this time (see Fig. 8, A-D) . However, at 24-48 h postischemia, V95-FN increases in the interstitial compartment surrounding tubular basement membranes (Fig. 11E) . A gradient of staining, ranging from greater intensity in cortical areas adjacent to the outer medulla to lesser intensity in cortical regions distant from it, is not readily detected, in contrast to the immunstaining pattern observed for EIIIA-FN (see Fig. 11B ). At 120 h postischemia, V95-FN is not present to the same extent as EIIIA (see Fig. 11C ) or total FN (see Fig. 9D ). Antibody recognizing V95 strongly outlines only some tubules in this location (Fig. 11F) .
In contralateral kidneys at all time points, FN containing V95 weakly localizes to the connective tissue of the capillary tuft and to Bowman's capsule (data not shown), as in the postischemic injured kidney at 0 h (see Fig. 11D ). None is detected in the luminal space at any time (data not shown). Faint, patchy immunostaining is infrequently seen in the interstitial compartment (data not shown). A similar pattern is observed in cortical regions of mock kidneys at all time points, except that interstitial staining is barely detectable (data not shown).
Thus in the cortex after ischemic injury, no FN isoforms are detected in the urinary space of the glomerulus. In addition, the FN isoform containing EIIIA and, to a lesser extent, V95-FN develops a gradient of expression, with more localizing in cortical regions near the outer medulla and less in regions distant from it. Both isoforms localize to the interstitium surrounding tubular basement membranes. FN containing EIIIB is not detected.
Plasma But Not Cellular FN is Voided in the Urine
Immunostaining with anti-total FN and anti-V95 antibodies indicated that FN localized to tubular lumens shortly after reperfusion (1-3 h) peaked when injury predominated (24-48 h) and later disappeared as regeneration continued (120 h reperfusion; see Figs. 2 and 8, respectively; 76). Loss of FN from tubular lumens could be due to excretion. To confirm this, urine collected at 24-h intervals from animals that had undergone unilateral renal ischemia was analyzed for the presence of plasma and/or cellular FN. Urine from mock-operated animals served as control. Urine containing equal amounts of protein were electrophoresed, and SDS gels were immunoblotted with either antitotal or anti-cellular FN antibody recognizing human EDA.
Immunoblotting with the anti-total FN antibody demonstrates that FN is voided in the urine in response to ischemia-reperfusion injury. Two patterns emerge. In some animals (n ϭ 3), total FN is voided at increasing levels (Fig. 12A) , beginning as early as 24 h after reperfusion, peaking 72-96 h after reperfusion and in some instances declining thereafter. In other animals (n ϭ 4), a biphasic excretion pattern is seen (Fig. 12A) . Total FN is voided at high levels 24 h after reperfusion, declines 48-72 h after reperfusion, and again increases from 72-120 h, reaching levels equivalent to that at the 24-h time point. In urine of mock operated or normal animals, total FN is excreted at very low levels (Fig. 12A) .
In contrast to the data with the anti-total FN antibody, immunoblotting with anti-cellular EDA antibody confirms that cellular FN synthesized by renal epithelia or connective tissue cells is not detected in the urine at any time after ischemia-reperfusion (Fig. 12B) . It is also not detected in urine collected from mock-operated animals (Fig. 12B) . Thus cellular FN is not excreted, suggesting that all the FN that is excreted is from the plasma and that it is plasma not cellular FN that is found in tubular lumens.
Distribution and Expression of FN Isoforms 6 Wk After Ischemic Injury
The observation that total FN-, EIIIA-, and V95-containing FN isoforms persist at high levels 120 h after reperfusion when repair from ischemic injury is almost complete and redifferentiation of the damaged tubular epithelium predominates (1, 72, 76) raised the question of whether the distribution and expression of FN isoforms containing EIIIA and/or V95 persists at later times.
At 6 wk postischemia, FN continues to localize at high levels in previously injured regions of the outer medulla, identified by the heterogeneous shapes and sizes of the regenerated tubules. Antibody against total FN strongly stains the interstitial compartment, sometimes concentrating at higher levels adjacent to basement membranes of renal tubules (Fig. 13A ). In contrast, antibodies to EIIIA and V95-FNs mainly identify tubular basement membranes of varying thicknesses, whereas other basement membranes are not outlined (Fig. 13, B-C, respectively) . The interstitial compartment contains some EIIIA and V95-FN, however, at significantly lower levels than that observed for total FN.
In the cortex, FN containing the EIIIA or V95 regions is not detected in association with basement membranes or the interstitium (data not shown); sclerosis of glomeruli also is not evident (data not shown).
FN containing EIIIB is not detected in either the outer medulla or cortex of the 6-wk postischemic kidney (data not shown). FN (C, D, G,  and H) . In the cortex of contralateral (A-B) and mock (E-F) kidneys, total FN outlines Bowman's capsule, the glomerular capillary tuft, and proximal and distal tubules; it also localizes to the interstitium. Total FN is absent, however, from the urinary space surrounded by Bowman's capsule (A, B, E, and F) and from tubular lumens of distal nephron segments (A, B, E, and F). Interstitial staining does not increase at 120 h (B, F). FN containing the EIIIA region highlights glomerular elements in contralateral (C-D) and mock kidneys (arrows, G-H), although to a lesser extent in the latter. The dashed lines in G-H demarcate Bowman's capsule. Renal tubules stain nonspecifically in G. Bar ϭ 28 m.
Thus EIIIA and V95-FNs are found in the 6-wk postischemic kidney, localizing to the basement membrane region of previously injured tubules. They are also found to a lesser extent in the surrounding interstitium.
DISCUSSION
We demonstrate using an in vivo model of unilateral renal ischemia that production of FN splice variants dramatically changes as a result of renal injury and repair (Table 1 ). In ischemic kidneys that are not reperfused (0 h), the alternatively spliced forms of FN, which contain the EIIIA, EIIIB, and/or V95 regions, are absent from the renal interstitium. However, at early times after reperfusion (1-3 h), FN containing EIIIA increases in this location in the outer medulla whereas FN containing V95 does not. The isoform containing V95, but not the EIIIA or EIIIB region, is found in a few lumens of the distal nephron. At 24-48 h postischemia, as further injury and regeneration coordinately occur, localization of both EIIIA-and V95-containing FN isoforms increases in the interstitial matrix in both the outer medulla and cortex, with the increase in EIIIA-FN being more dramatic. The V95-containing FN isoform, but not that containing EIIIA, also frequently fills the luminal space. As regeneration continues at 120 h after reperfusion, EIIIA-and V95-containing FN strongly localize to the interstitial compartment, and V95-FN is no longer detected in tubular lumens. Luminal FN is ultimately excreted in the urine. Six weeks after ischemic injury, FN containing EIIIA and/or V95 persists around some renal tubules.
Our data using polyclonal and monoclonal antibodies specific for unique regions of the various isoforms of FN indicate that luminal FN originates from plasma. FN in tubular spaces was detected by immunohistochemistry with antibodies recognizing both total and V95-FNs but not with antibodies against the EIIIA-or EIIIB-containing cellular isoforms. In addition, FN excreted in the urine was not detected by antibody specific for cellular FN.
It is unclear how plasma FN enters the luminal space. There is no evidence that it is made by other cell types in addition to hepatocytes (61) . Furthermore, our data suggest that luminal plasma FN does not originate from damage to the glomerular filtration barrier, which normally is impermeant to plasma proteins. Total or V95-FNs, with molecular weights of ϳ440 kDa, were not detected in Bowman's space at any time after ischemia. We believe it likely, therefore, that plasma proteins, including FN, extravasate from interstitial blood vessels into the interstitial space from where it penetrates damaged tubules and enters the lumen. Permeability changes in interstitial blood vessels would allow the escape of plasma FN into the interstitium. In combination with tubulorrhexis and/or disruption to the epithelial permeability barrier (59, 69) , plasma FN would then gain entry into tubular lumens. Once in the lumen of the injured tubule, plasma FN concentrates in more distal nephron segments.
Under these circumstances, luminal plasma FN might play a very significant role in the pathophysiology of acute renal failure. Our data indicate that within the first 48 h of ischemic injury, FN is detected by immunohistochemistry in the luminal space of the injured kidney while simultaneously being excreted in the urine. Although we have no evidence plasma FN is occluding the lumen, the high concentration of plasma FN in this location may suggest that its movement is retarded. This may occur through the formation of obstructive complexes with other molecules such as the Heymann antigen gp330 (39) on microvilli shed in response to injury (16, 65) as well as other cellular debris, contributing to the formation of casts. We do not believe plasma FN adheres to sloughed dead or viable cells in the luminal space, because FN fibrils, which assemble on cell-FN interactions (27, 71, (73) (74) , are not detected. Ultimately, all plasma FN is excreted, indicating that any obstruction is not permanent (see Figs. 2H and 8H ).
We also demonstrate that after ischemic injury the FN isoforms containing the EIIIA and V95 regions but not EIIIB localize to the renal interstitium surrounding tubular basement membranes. Before injury, FN containing EIIIA or V95 is not detected in this location. Within 3 h of reperfusion, however, an increase in Immunoblots of urine representing equal amounts of protein resolved by 6% SDS-PAGE, reacted with chemiluminescence reagents. A and B: 5 and 10 g protein/lane, respectively. Urine was collected at 24-h intervals from animals that had undergone unilateral renal ischemia or from mock-operated animals; animals were housed in metabolic cages. Each immunoblot is from 1 representative animal. In the postischemic animal, antibody recognizing total FN (A) shows that FN is excreted in the urine in 2 patterns. In the first, it is voided at increasing levels from 24-120 h after reperfusion with high levels predominating between 72-120 h. In the second, a biphasic pattern is observed. High levels of FN are initially excreted at 24 h after reperfusion, followed by a precipitous decrease and subsequent increase that persists at 120 h. In the mock animal, fibronectin is excreted at very low levels, comparable to that detected in the urine of normal animals. Note the lower molecular weight breakdown fragments of FN excreted in the urine. EIIIA but not V95-FN is observed in the interstitial matrix of the outer medulla and continues to increase at 24-48 h after injury. Although V95-FN increases somewhat at this time, a parallel rise is not detected. Both persist at high levels in the renal interstitium 120 h after reperfusion.
The upregulation of FN isoforms suggests that ischemic injury may stimulate a signal regulating the production of the alternatively spliced forms. Transforming growth factor-␤ (TGF-␤), a multifunctional cytokine that operates in either a paracrine or autocrine manner, stimulates fibronectin synthesis (30) and regulates production of the EIIIA-FN isoform by acting on FN pre-mRNA (13, 35) . It is derived from a number of cell types including platelets (5), wound macrophages (49) , and fibroblasts/myofibroblasts (75), as well as injured proximal tubular epithelial cells (10) . It has a known role in the pathogenesis of renal disease (11, 58) and is believed to promote tissue regeneration after renal injury (8, 10) . It is unclear which cells at the various time points after reperfusion produce TGF-␤ in the in vivo model of unilateral renal ischemia used in this study. Whether TGF-␤ acts in a paracrine or autocrine fashion on injured epithelial or connective tissue cells (e.g., infiltrating macrophages, fibroblasts/ myofibroblasts) to promote the synthesis, secretion, and deposition into the extracellular matrix of FN containing the EIIIA region also needs to be determined. TGF-␤ when administered in vitro increases expression of EIIIA-FN mRNA by proximal tubule cells (35, 66) ; its immunoneutralization in vivo in a bilateral model of renal injury also attenuates the rise in FN containing EIIIA (9) . The production of TGF-␤ and other paracrine growth factors may explain the unusual gradient of staining for EIIIA-FN in the cortex, which is intense in regions adjacent to the outer medulla (see Fig. 11B ). Paracrine growth factors may also be responsible for the observation that EIIIA-FN is not detected in the cortex until 24 h after reperfusion (Fig.  11B) even though in the outer and inner stripes it is present at high levels soon after reperfusion (1-3 h postischemia; see Fig. 5, C-D) .
Growth factors produced by the injured kidney may also explain the appearance of the alternatively spliced forms in the contralateral kidney detected by immunostaining. The FN isoform containing EIIIA was detected within hours in the contralateral kidney, whereas the FN isoform containing V95 was detected later. Both persisted at the latest time point we examined, although levels did not increase from that seen initially and overall were less than that seen in the ischemic kidney. Perhaps growth factors, such as TGF-␤1, released by the injured ischemic kidney enter the systemic circulation; in this location, it may act on the contralateral kidney to stimulate the production and accumulation of FN containing EIIIA and/or V95. Alternatively, the experimental procedure of unilaterally clamping the renal artery and vein may have resulted in some generalized reduction in blood pressure, resulting in reduced perfusion of the contralateral kidney.
In the postischemic kidney, the role of FN containing EIIIA is unknown; however, our data indicate that it may be necessary for regeneration. EIIIA-FN is widely expressed during organogenesis and tissue remodelling in the embryo (20-21, 43-44, 47, 64) and during wound healing of various tissue types (2-3, 7, 14, 17, 20, 25, 28, 41-42, 60, 67) . In each of these cases, FN containing EIIIA may be required for cell migration, proliferation, and differentiation. The association of EIIIA-FN with tubular basement membranes may promote migration of remaining epithelial cells after damaged cells have exfoliated, as well as the spreading of adherent epithelia to fill in denuded areas of basement membrane. Similarly, it may stimulate epithelial proliferation, which occurs during this time and is necessary for repopulation of the damaged tubule (72) . These cellular responses are key elements of epithelial redifferentiation after renal ischemic injury (62, 76) . It would be interesting to examine at the ultrastructural level whether EIIIA-FN is indeed an integral component of regenerating basement membranes and whether in this location it mediates these cell-extracellular matrix interactions, perhaps by inducing the expression of novel extracellular matrix receptors, such as the ␣5␤1 integrin, the major fibronectin receptor, and/or contributing to the altered distribution of other integrins (76) .
FN containing EIIIA may also play a role in the fibrotic response after renal ischemic injury. In this Distribution of total fibronectin (FN), the extra type III A (EIIIA) segment, the extra type III B (EIIIB) segment, and the V95 subsegment was analyzed by immunofluorescence microscopy using antitotal FN antibody or anti-segment-specific antibodies. Patterns of staining that were observed include basement membrane zone (B); renal interstitium (I); renal corpuscle (C); tubular lumen of distal nephron (L). Fluorescence staining intensity was subjectively graded as absent (Ϫ); faint (ϩ); moderate (ϩϩ); strong (ϩϩϩ); g**, strong gradient of staining; g*, faint gradient of staining. p.i., Postischemic.
regard, FN is believed to be the first extracellular matrix molecule deposited in renal interstitial fibrosis (18) . In the liver, FN containing EIIIA activates the conversion of normal hepatic lipocytes into myofibroblast-like cells, a critical event in the initiation of fibrogenesis in the liver (31) . In the formation of granulation tissue in wounded skin, EDA FN is necessary for induction of the myofibroblastic phenotype by TGF-␤1 (57) . Whether deposition of FN containing EIIIA in the postischemic kidney is necessary for the conversion of stromal fibroblasts and/or perivascular cells into myofibroblast-like cells (18) is unknown. However, TGF-␤ mediates this activation (15) and also stimulates production of FN containing EIIIA (6) . We see that in the injured kidney FN containing EIIIA is expressed soon after reperfusion, continues to increase in an expanded interstitium, and persists weeks later in association with thickened basement membranes. Perhaps deposition of EIIIA-FN is the key extracellular matrix component that initiates renal fibrosis after ischemic injury.
More is known about the role of FN containing the V95 region, which in the rat is a component of both plasma and cellular FNs. FN exists as a dimeric glycoprotein, and the V95 region must be present in at least one subunit for its secretion to take place (for review, see Refs. [51] [52] . Our immunostaining data clearly show that although the EIIIA isoform is present in high amounts in the renal interstitium after ischemic injury, levels of V95 are not necessarily comparable. Similar results have been obtained by immunohistochemistry in skeletal and heart muscle, lung parenchyma, small intestine, pancreas, and peripheral nerve (46) . This apparent discrepancy could arise from the presence of the V95 region in only one subunit of the FN dimer and/or from differences in antibody sensitivity or epitope masking.
These same reasons could explain why the FN isoform containing the V95 region is not detected in tubular lumens at the same frequency as total FN, which recognizes both the plasma and cellular forms. The V95 region in the rat is one of three variants produced by alternative splicing of the V region exon (for review, see Refs. 19, 51-52). These variants include V120, which contains all V120 region amino acids, V95, which lacks the first 25 amino acids, and V0, which lacks the entire V region. In rat plasma FN, ϳ50% of the FN subunits are V0 and 50% are a combination of V120 and V95 (54) . Considering that less than 50% of the FN subunits circulating in plasma are V95, it is not surprising that the frequency of the V95 isoform in tubular lumens is not equivalent to that observed with the total FN antibody.
At 6 wk postischemic injury, FN isoforms containing EIIIA and V95 strongly localize to thickened basement membranes of some tubules that initially were damaged and appear incompletely regenerated; localization to the surrounding interstitium is weak. Staining with anti-total FN antibody indicates that total FN is found in tubular basement membranes and is strongly expressed in the interstitial compartment. The data suggest incomplete recovery of some regions of the postischemic kidney. In addition, plasma FN, possibly escaping from interstitial blood vessels, appears to be trapped in the connective tissue compartment, having been deposited into the extracellular matrix. It is possible that plasma FN is prevented from entering the luminal space either because the thickened basement membranes, containing EIIIA and V95 FNs, inhibit its passage and/or the epithelial permeability barrier is reestablished.
Our observation of incomplete recovery 6 wk after unilateral ischemic injury may be clinically relevant. In the patient population, the postischemic kidney has a tremendous capacity to completely regenerate, restoring normal renal function. However, it is possible that some nephrons do not completely recover. We believe that our observation in the unilateral model showing incomplete repair of some nephron segments could indicate heterogeneity of nephron function postischemia (4, 23) . Long-term effects could result in chronic renal failure, glomerulosclerosis, and tubulointerstitial damage (63) . Similar processes may ultimately occur in patients suffering from ischemic injury.
In conclusion, we show that in response to ischemic injury, the FN isoforms containing the EIIIA and V95 regions that are not normally expressed in the renal interstitium are significantly upregulated, suggesting a possible dual role in regeneration of the damaged kidney and in fibrosis. Tubular FN originates from plasma and may contribute to obstruction. Determining the role of extracellular matrix molecules in renal ischemic injury and repair and how they interact with damaged and regenerating cells may facilitate our understanding of the pathogenesis of acute renal failure. Knowledge of these processes may contribute to the identification of novel therapeutics aimed at limiting injury or speeding recovery.
